Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 40, 2008 - Issue 9
Submit an article Journal homepage
337
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden

Annika Bergman From the Swedish Institute for Health Economics,Correspondence[email protected]
,
Jonas Hjelmgren From the Swedish Institute for Health Economics,
,
Åke Örtqvist Department of Medicine, Infectious Diseases Unit, Karolinska Institute, Solna, Sweden; Department of Communicable Diseases Control and Prevention, Stockholm County Council, Sweden
,
Torbjørn Wisløff Norwegian Health Services Research Centre,
,
Ivar Sønbø Kristiansen Norwegian Health Services Research Centre,; Institute of Health Management and Health Economics, University of Oslo, Norway
,
Liselotte Diaz Högberg Swedish Institute for Infectious Disease Control,
,
Kristina M-S Persson Department of Communicable Diseases Control and Prevention, Region Skåne, Sweden
&
Ulf Persson From the Swedish Institute for Health Economics,
 show all
Pages 721-729 | Received 14 Jan 2008, Published online: 08 Jul 2009

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Johnna Perdrizet, Raymond A. Farkouh, Emily K. Horn, Kyla Hayford, Heather L. Sings & Matt D. Wasserman. (2022) The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines. Expert Review of Vaccines 21:4, pages 499-511.
Read now
Xu-Hao Zhang, Oscar Leeuwenkamp, Kyu-Bin Oh, Young Eun Lee & Chul-Min Kim. (2018) Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea. Human Vaccines & Immunotherapeutics 14:1, pages 85-94.
Read now
Anouk Speets, Judith Wolleswinkel & Cristina Cardoso. (2011) Societal costs and burden of otitis media in Portugal. Journal of Multidisciplinary Healthcare 4, pages 53-62.
Read now
Scott D Grosse, Lisa A Prosser, Keiko Asakawa & David Feeny. (2010) QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique. Expert Review of Pharmacoeconomics & Outcomes Research 10:3, pages 293-308.
Read now

Articles from other publishers (20)

Tinevimbo Shiri, Kamran Khan, Katherine Keaney, Geetanjali Mukherjee, Noel D. McCarthy & Stavros Petrou. (2019) Pneumococcal Disease: A Systematic Review of Health Utilities, Resource Use, Costs, and Economic Evaluations of Interventions. Value in Health 22:11, pages 1329-1344.
Crossref
Tara A. Lavelle, Brittany N. D’Cruz, Babak Mohit, Wendy J. Ungar, Lisa A. Prosser, Kate Tsiplova, Montserrat Vera-Llonch & Pei-Jung Lin. (2018) Family Spillover Effects in Pediatric Cost-Utility Analyses. Applied Health Economics and Health Policy 17:2, pages 163-174.
Crossref
Liv S. Nymark, Tarang Sharma, Alexander Miller, Ulrika Enemark & Ulla Kou Griffiths. (2017) Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used. Vaccine 35:49, pages 6828-6841.
Crossref
Marisa Holubar, Maria Christina Stavroulakis, Yvonne Maldonado, John P. A. Ioannidis & Despina Contopoulos-Ioannidis. (2017) Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis. PLOS ONE 12:3, pages e0172414.
Crossref
Matthew R. Moore & Cynthia G. Whitney. (2015) Use of Pneumococcal Disease Epidemiology to Set Policy and Prevent Disease during 20 Years of the Emerging Infections Program. Emerging Infectious Diseases 21:9, pages 1551-1556.
Crossref
David Bin-Chia Wu, Nathorn Chaiyakunapruk, Huey-Yi Chong & Philippe Beutels. (2015) Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006–2014). Vaccine 33:14, pages 1633-1658.
Crossref
Katelijne van de Vooren, Silvy Duranti, Alessandro Curto & Livio Garattini. (2013) Cost Effectiveness of the New Pneumococcal Vaccines: A Systematic Review of European Studies. PharmacoEconomics 32:1, pages 29-45.
Crossref
Fernando De la Hoz-Restrepo, Carlos Castañeda-Orjuela, Angel Paternina & Nelson Alvis-Guzman. (2013) Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines. Vaccine 31, pages C80-C87.
Crossref
Wantanee Kulpeng, Pattara Leelahavarong, Waranya Rattanavipapong, Vorasith Sornsrivichai, Henry C. Baggett, Aronrag Meeyai, Warunee Punpanich & Yot Teerawattananon. (2013) Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context?. Vaccine 31:26, pages 2839-2847.
Crossref
Teresa Jackowska, Joanna Zaleska-Ponganis & Dominik Dziurda. 2013. Respiratory Regulation - Clinical Advances. Respiratory Regulation - Clinical Advances 257 266 .
Richard PitmanDavid FismanGregory S. ZaricMaarten PostmaMirjam KretzschmarJohn EdmundsMarc Brisson. (2012) Dynamic Transmission Modeling. Medical Decision Making 32:5, pages 712-721.
Crossref
Richard Pitman, David Fisman, Gregory S. Zaric, Maarten Postma, Mirjam Kretzschmar, John Edmunds & Marc Brisson. (2012) Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5. Value in Health 15:6, pages 828-834.
Crossref
Yoko IbukaA. David PaltielAlison P. Galvani. (2012) Impact of Program Scale and Indirect Effects on the Cost-Effectiveness of Vaccination Programs. Medical Decision Making 32:3, pages 442-446.
Crossref
Bianca Rezende Lucarevschi, Ana Maria de Ulhôa Escobar & Sandra Grisi. (2012) Custos hospitalares da meningite causada por Streptococcus pneumoniae na cidade de São José dos Campos, São Paulo, Brasil. Cadernos de Saúde Pública 28:4, pages 740-748.
Crossref
Åsa By, Patrik Sobocki, Arne Forsgren & Sven-Arne Silfverdal. (2012) Comparing Health Outcomes and Costs of General Vaccination with Pneumococcal Conjugate Vaccines in Sweden: A Markov Model. Clinical Therapeutics 34:1, pages 177-189.
Crossref
Nathorn Chaiyakunapruk, Ratchadaporn Somkrua, Raymond Hutubessy, Ana Maria Henao, Joachim Hombach, Alessia Melegaro, John W Edmunds & Philippe Beutels. (2011) Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools. BMC Medicine 9:1.
Crossref
Chantal W.B. Boonacker, Pieter H. Broos, Elisabeth A.M. Sanders, Anne G.M. Schilder & Maroeska M. Rovers. (2011) Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children. PharmacoEconomics 29:3, pages 199-211.
Crossref
Anouk M. SpeetsJudith H. Wolleswinkel, Arne Forsgren & Patrik A. Sobocki. (2011) Use of medical resources and indirect costs of otitis media in Sweden. Scandinavian Journal of Public Health 39:2, pages 137-146.
Crossref
Sven Arne Silfverdal, Stefan Berg, Claes Hemlin & Iiro Jokinen. (2009) The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine. Vaccine 27:10, pages 1601-1608.
Crossref
. (2013) Universal pneumococcal 7-valent vaccination cost effective. PharmacoEconomics & Outcomes News 565:1, pages 1-1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.